- Previous Close
0.0750 - Open
0.0000 - Bid --
- Ask 0.0700 x --
- Day's Range
0.0750 - 0.0750 - 52 Week Range
0.0100 - 0.1400 - Volume
0 - Avg. Volume
2,324 - Market Cap (intraday)
3.586M - Beta (5Y Monthly) 1.55
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. MYND Life Sciences Inc. is based in Port Coquitlam, Canada.
www.myndsciences.comRecent News: MYND.CN
View MorePerformance Overview: MYND.CN
Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MYND.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MYND.CN
View MoreValuation Measures
Market Cap
3.59M
Enterprise Value
6.59M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.50M
Price/Book (mrq)
--
Enterprise Value/Revenue
6.59M
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-151.46%
Return on Equity (ttm)
--
Revenue (ttm)
1
Net Income Avi to Common (ttm)
-542.57k
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
497
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-658.04k